Evaluation of disparities in the incidence, presentation, and treatment of pediatric differentiated thyroid cancer in the United States (2000–2022)

Declines in reported pediatric thyroid cancer incidence, particularly among the smallest tumor sizes, after 2018 may be attributable to application of thyroid cancer management guidelines. However, the continued increase among those presenting with larger tumor sizes may support a true continued increase in incidence among some groups. The greater proportion of non-White children being diagnosed with larger tumors could be due to inequities related to timely access to care, differential application of thyroid management guidelines, differences in cancer subtypes, or other factors. These findings warrant further exploration when additional years of data are available.